Washington: The Moderna vaccine provides strong protection against Kovid for children up to the age of 12. Moderna also said it is another option for children who wish to be vaccinated in the United States.
Moderna said it would soon release a study on children to the US Department of Food and Drugs.
The company has conducted a study on 3,700 children aged 12 to 17 years. The vaccine triggers the same symptoms of immunization in children as in adults. Moderna has also shown general effects.
It is clear that Kovid does not appear in children who received two doses of the vaccine. "The vaccine has proven to be effective at 93% within two weeks of receiving the first dose," the company said in its press release.
Children are less likely to be exposed to serious effects of Kovid. In particular, children account for about a quarter of all US Covid cases. 14 is.
Pfizer and BioTech vaccines have already been approved for use by children under the age of 12 in the US.